ExodusPoint Capital Management’s Sage Therapeutics SAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-26,125
Closed -$238K 1951
2025
Q2
$238K Sell
26,125
-53,235
-67% -$392K ﹤0.01% 1280
2025
Q1
$631K Sell
79,360
-60,388
-43% -$442K 0.01% 1058
2024
Q4
$759K Buy
+139,748
New +$854K 0.01% 1031
2024
Q2
Sell
-102,305
Closed -$1.92M 1929
2024
Q1
$1.92M Buy
102,305
+74,341
+266% +$1.71M 0.01% 714
2023
Q4
$606K Sell
27,964
-2,107
-7% -$41.8K ﹤0.01% 980
2023
Q3
$619K Buy
+30,071
New +$868K 0.01% 1163
2023
Q1
Sell
-14,116
Closed -$538K 2082
2022
Q4
$538K Sell
14,116
-55,117
-80% -$2.1M 0.01% 1143
2022
Q3
$2.71M Sell
69,233
-73,722
-52% -$2.85M 0.04% 645
2022
Q2
$4.62M Sell
142,955
-27,955
-16% -$937K 0.06% 438
2022
Q1
$5.66M Buy
+170,910
New +$6.43M 0.07% 339
2021
Q4
Sell
-52,134
Closed -$2.31M 2539
2021
Q3
$2.31M Buy
52,134
+21,554
+70% +$988K 0.03% 674
2021
Q2
$1.74M Buy
30,580
+26,433
+637% +$1.87M 0.02% 749
2021
Q1
$310K Buy
4,147
+1,752
+73% +$144K ﹤0.01% 1644
2020
Q4
$207K Sell
2,395
-20,915
-90% -$1.54M ﹤0.01% 1716
2020
Q3
$1.43M Sell
23,310
-14,476
-38% -$734K 0.03% 526
2020
Q2
$1.57M Buy
+37,786
New +$1.37M 0.04% 527
2019
Q3
Sell
-3,402
Closed -$623K 1602
2019
Q2
$623K Buy
+3,402
New +$580K 0.02% 387

Other funds holding SAGE